ArticleCurrent medicinal chemistry2025

MEF2C is a Potential Prognostic Biomarker and is Correlated with Immune Infiltrates in Lung Adenocarcinoma.

Ke Liang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.